Plan to vaccinate over 440 million children ready: Covid panel chief

The National Technical Advisory Group on Immunisation is working on a comprehensive policy on a booster shot and additional doses in the next two weeks

vaccine
Representative image
Agencies
1 min read Last Updated : Nov 30 2021 | 4:12 AM IST
With the emergence of a new coronavirus variant of concern — Omicron — Covid-19 task force Chairman N K Arora on Monday said a comprehensive policy on a booster dose and additional doses will be announced in two weeks. 

He said a plan has also been developed to vaccinate India’s 440-million-plus children.

“The National Technical Advisory Group on Immunisation is working on a comprehensive policy on a booster shot and additional doses in the next two weeks. The policy will deal with who will require the vaccine, when and how. This needs to be seen in the context of a new variant of concern. The relevance and effectiveness of the current vaccines on offer will also become apparent with time,” said Arora.

“There is a difference between a booster dose and an additional dose. A booster dose is given in a predefined period after two primary doses. An additional dose is only given to those who have problems with their immune function, even after the primary dose. If a person’s immune function is not appropriately built, you give them an additional dose,” he added.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineIndia vaccination

Next Story